Companies you'll love to work for


Boston, MA, USA


Biotechnology · DeepTech · Health


51-200 employees


Series B

founded in


Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies can be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited.

Something looks off?
Open jobs at Ensoma
Powered by Getro